Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 17;18(1):34.
doi: 10.1186/s12954-021-00481-9.

"Drugs are a taboo": a qualitative and retrospective study on the role of education and harm reduction strategies associated with the use of psychoactive substances under the age of 18

Gabriela Almeida Pinto da Silva  1 , Catarina Pinto Pereira  1 , Marta Sofia de Sousa Pinto  2
Affiliations

"Drugs are a taboo": a qualitative and retrospective study on the role of education and harm reduction strategies associated with the use of psychoactive substances under the age of 18

Gabriela Almeida Pinto da Silva et al. Harm Reduct J. .

Abstract

Background: The use of psychoactive substances frequently starts at a younger age than adulthood. Considering the perspective of young people, this retrospective study tried to provide them with a role in identifying their own needs regarding drug use and interventions focused on it; the obstacles in accessing both general health and harm reduction services; the changes needed for a more effective, congruent and empowering response to the use of psychoactive substances before the age of 18.

Methods: The study was divided into two parts having both parts a qualitative focus. In the first part of the study, an online questionnaire was sent to all harm reduction teams and two focus groups were carried out with eight harm reduction professionals and six people who use(d) drugs. The second part used an online questionnaire applied to 143 participants aged between the age of 18 and 25 complemented by two semi-structured interviews.

Results: The need for education about psychoactive substances, namely in the educational context; the lack of information about available services; and the need for confidentiality were the most mentioned issues by the young people. Also, the informal network played a significant role in the participants relationship with psychoactive substances.

Conclusions: The lack of information was the most highlighted obstacle. Also, there is a confluence of various vulnerabilities such as being under 18, using drugs and the different social situations that they live in. To improve policy and practice regarding drug use among young people, harm reduction interventions must be scaled-up as well as intentionally driven to empower youth to deal with. School environment was chosen by participants as one of the elected environments to implement harm reduction services.

Keywords: Drug education; Harm reduction; Intervention; Psychoactive substances; Qualitative; Retrospective study; Young people.

PubMed Disclaimer

References

    1. Global Commission on Drug Policy. Classification of Psychoactive Substances: When Science was left behind. 2019.
    1. Chadi N, Bagley SM, Hadland SE. Addressing adolescents’ and young adults’ substance use disorders. Med Clin North Am. 2018;102(4):603–620. doi: 10.1016/j.mcna.2018.02.015. - DOI - PubMed
    1. Jessor R. Risk behavior in adolescence: a psychosocial framework for understanding and action. J Adolesc Health. 1991;12(8):597–605. doi: 10.1016/1054-139X(91)90007-K. - DOI - PubMed
    1. Real D, Vieira R. Psychoactive substance abuse in adolescence and social work in the school: a point a view from professionals and students in Castelo Branco, Portugal. Child Adolesc Soc Work J. 2019;36(3):329–335. doi: 10.1007/s10560-019-00603-0. - DOI
    1. Riley M, Patterson V, Lane JC, Won KM, Ranalli L. The adolescent champion model: primary care becomes adolescent-centered via targeted quality improvement. J Pediatr. 2018;193(1):229–236. doi: 10.1016/j.jpeds.2017.09.084. - DOI - PubMed

Substances